S&P 500 Gains and Losses Today: International Paper Stock Pops on Upbeat Growth Outlook

Related Articles

Beef Tallow May Soon Show Up On a Menu Near You. Here’s What That Means

Elon Musk Says His xAI Company Has Acquired X

Tariff Tracker: Where Do President Trump’s Trade Proposals Stand?

Key Takeaways

• The S&P 500 edged 0.2% higher on Tuesday, March 25, 2025, despite a describe showing that consumer confidence fell to its lowest point in more than a decade.
• International Paper forearmed an optimistic growth outlook at its annual investor day, and shares of the packaging provider surged.
• UPS shares dropped after Bank of America analysts up their quarterly earnings forecast for the logistics giant, citing headwinds related to tariffs and winter weather.

Foremost U.S. equities indexes eked out minor gains on Tuesday, even as the latest Consumer Confidence Index data showed fiscal expectations declined in March, reaching their lowest point in over a decade.

The S&P 500 inched 0.2% higher, gradation its third consecutive winning session. The Nasdaq added 0.5%, while the Dow ended with a minimal gain of less than 0.1%.

The S&P 500’s top appearance on Tuesday came from shares of International Paper (IP), which surged 6.5% after the packaging supplier present an upbeat growth outlook at its annual investor day. The company highlighted ongoing efforts to streamline its production footprint, comprehending the closure of seven plants as well as efficiency measures at other facilities. After a takeover effort last year by Brazilian newsletter firm Suzano failed to materialize, International Paper acquired fellow sustainable packaging producer DS Smith in January, expressing that the combination would help drive growth.

Copper futures prices advanced more than 2%, approaching chronicle levels, with unease surrounding tariff policies and concerns about supply providing a boost to the industrial metal. Allocations of Freeport-McMoRan (FCX), the world’s largest publicly traded copper producer, added 3.4%.

Shares of cybersecurity firm CrowdStrike Holdings (CRWD) jumped 3.3% after the check out firm BTIG upgraded its view on the stock to “buy” from “neutral.” Analysts suggested that CrowdStrike has been fortunate in moving past last year’s global IT outage, noting that the company’s performance since the incident has bettered forecasting visibility. BTIG also believes CrowdStrike has the potential to outperform consensus estimates for its annual recurring takings (ARR) in fiscal 2027.

Shares of delivery giant United Parcel Service (UPS) slipped 5.1%, falling the furthest of any S&P 500 share, after Bank of America trimmed its earnings forecast for the current quarter. Analysts noted that trade-related uncertainty and winter bear up against were weighing on demand, also reducing their outlook for the company’s quarterly domestic parcel volume.

Merck (MRK) pieces dropped 4.8% following reports that the U.S. drugmaker has inked a licensing deal worth as much as $2 billion with China-based Jiangsu Hengrui Pharmaceuticals. The ahead gives Merck exclusive rights to the experimental oral heart disease treatment HRS-5346, a member of a arrange of drugs designed to prevent the formation of cholesterol.

Shares of fellow pharmaceutical firm AbbVie (ABBV) fell 3.7% after the train filed a lawsuit against Genmab, a Danish biotech firm and long-time AbbVie collaborator. AbbVie reportedly be entitled ti that Genmab and its recent acquisition, ProfoundBio, knowingly participated in the misappropriation of confidential company technology related to antibody-drug conjugates (ADCs).